First PFA In The US: FDA Approves Medtronic’s PulseSelect For AF Ablation

Medtronic's PulseSelect is the first pulse field ablation technology to earn FDA approval and the company plans to launch it in early 2024. PulseSelect PFA earned a CE mark in November.

pulseselect
• Source: Medtronic

Medtronic appears to have won the race to becoming the first company to launch a pulse field ablation system in the US.

The US Food and Drug Administration approved Medtronic’s PulseSelect pulsed field ablation (PFA) system for the treatment of both paroxysmal...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Approvals

More from Policy & Regulation